{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:39:04Z","timestamp":1761597544729},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s13277-014-2619-0","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T21:14:46Z","timestamp":1411074886000},"page":"233-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"2619_CR1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/nyas.12112","volume":"1291","author":"AM Davies","year":"2013","unstructured":"Davies AM, Weinberg U, Palti Y. Tumor treating fields: a new frontier in cancer therapy. Ann N Y Acad Sci. 2013;1291:86\u201395.","journal-title":"Ann N Y Acad Sci"},{"key":"2619_CR2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00109-013-1055-8","volume":"91","author":"J Wu","year":"2013","unstructured":"Wu J, Wei JJ. HMGA2 and high-grade serous ovarian carcinoma. J Mol Med (Berl). 2013;91:1155\u201365.","journal-title":"J Mol Med (Berl)"},{"key":"2619_CR3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00404-013-2856-2","volume":"288","author":"Y Chen","year":"2013","unstructured":"Chen Y, Zhang L, Hao Q. Olaparib: a promising PARP inhibitor in ovarian cancer therapy. Arch Gynecol Obstet. 2013;288:367\u201374.","journal-title":"Arch Gynecol Obstet"},{"key":"2619_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/path.4205","volume":"230","author":"WD Foulkes","year":"2013","unstructured":"Foulkes WD, Shuen AY. In brief: BRCA1 and BRCA2. J Pathol. 2013;230:347\u20139.","journal-title":"J Pathol"},{"key":"2619_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/515178","volume":"28","author":"DT Graves","year":"1999","unstructured":"Graves DT. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis. 1999;28:482\u201390.","journal-title":"Clin Infect Dis"},{"key":"2619_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/clc.4960250403","volume":"25","author":"U Ikeda","year":"2002","unstructured":"Ikeda U, Matsui K, Murakami Y, Shimada K. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol. 2002;25:143\u20137.","journal-title":"Clin Cardiol"},{"key":"2619_CR7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","volume":"2","author":"SA Luther","year":"2001","unstructured":"Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2:102\u20137.","journal-title":"Nat Immunol"},{"key":"2619_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","volume":"71","author":"MJ Robertson","year":"2002","unstructured":"Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71:173\u201383.","journal-title":"J Leukoc Biol"},{"key":"2619_CR9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/0008-5472.CAN-08-2164","volume":"69","author":"X Li","year":"2009","unstructured":"Li X, Loberg R, Liao J, Ying C, Snyder LA, et al. A destructive cascade mediated by MCP-1 facilitates prostate cancer growth in bone. Cancer Res. 2009;69:1685\u201392.","journal-title":"Cancer Res"},{"key":"2619_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10585-008-9226-7","volume":"26","author":"Y Lu","year":"2009","unstructured":"Lu Y, Chen Q, Corey E, Xie W, Fan J, et al. Activation of MCP-1\/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis. 2009;26:161\u20139.","journal-title":"Clin Exp Metastasis"},{"key":"2619_CR11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/stem.673","volume":"29","author":"Y Hasegawa","year":"2011","unstructured":"Hasegawa Y, Takahashi N, Forrest AR, Shin JW, Kinoshita Y, et al. CC chemokine ligand 2 and leukemia inhibitory factor cooperatively promote pluripotency in mouse induced pluripotent cells. Stem Cells. 2011;29:1196\u2013205.","journal-title":"Stem Cells"},{"key":"2619_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2567.2011.03443.x","volume":"133","author":"VM Shpacovitch","year":"2011","unstructured":"Shpacovitch VM, Feld M, Holzinger D, Kido M, Hollenberg MD, et al. Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-gamma on human neutrophils and monocytes. Immunology. 2011;133:329\u201339.","journal-title":"Immunology"},{"key":"2619_CR13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","volume":"267","author":"G Soria","year":"2008","unstructured":"Soria G, Ben-Baruch A. The inflammatory chemokines MCP-1 and CCL5 in breast cancer. Cancer Lett. 2008;267:271\u201385.","journal-title":"Cancer Lett"},{"key":"2619_CR14","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.5301\/JBM.2012.9345","volume":"27","author":"JL Steiner","year":"2012","unstructured":"Steiner JL, Murphy EA. Importance of chemokine (CC-motif) ligand 2 in breast cancer. Int J Biol Markers. 2012;27:e179\u201385.","journal-title":"Int J Biol Markers"},{"key":"2619_CR15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jnci\/djq044","volume":"102","author":"J Zhang","year":"2010","unstructured":"Zhang J, Lu Y, Pienta KJ. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst. 2010;102:522\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"2619_CR16","doi-asserted-by":"crossref","first-page":"e54073","DOI":"10.1371\/journal.pone.0054073","volume":"8","author":"X Li","year":"2013","unstructured":"Li X, Tai HH. Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein-1 (MCP-1)\/chemokine (C-C motif) ligand 2 (MCP-1) and recruits macrophages to promote invasion of lung cancer cells. PLoS One. 2013;8:e54073.","journal-title":"PLoS One"},{"key":"2619_CR17","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfs555","volume":"28","author":"SJ Seok","year":"2013","unstructured":"Seok SJ, Lee ES, Kim GT, Hyun M, Lee JH, et al. Blockade of MCP-1\/CCR2 signalling ameliorates diabetic nephropathy in db\/db mice. Nephrol Dial Transplant. 2013;28:1700\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"2619_CR18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s13277-012-0610-1","volume":"34","author":"J Bai","year":"2013","unstructured":"Bai J, Li X, Tong D, Shi W, Song H, et al. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer. Tumour Biol. 2013;34:805\u20139.","journal-title":"Tumour Biol"},{"key":"2619_CR19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1089\/dna.2011.1520","volume":"31","author":"J Bai","year":"2012","unstructured":"Bai J, Song H, Cai C, Zhang M, Xu S, et al. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease. DNA Cell Biol. 2012;31:1058\u201363.","journal-title":"DNA Cell Biol"},{"key":"2619_CR20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10753-013-9605-3","volume":"36","author":"H Song","year":"2013","unstructured":"Song H, Ma S, Cha Z, Chen L, Tong D, et al. T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV\u2009+\u2009non-Hodgkin lymphomas. Inflammation. 2013;36:793\u20139.","journal-title":"Inflammation"},{"key":"2619_CR21","doi-asserted-by":"crossref","first-page":"e25474","DOI":"10.4161\/onci.25474","volume":"2","author":"M Li","year":"2013","unstructured":"Li M, Knight DA, Synder L, Smyth MJ, Stewart TJ. A role for MCP-1 in both tumor progression and immunosurveillance. Oncoimmunology. 2013;2:e25474.","journal-title":"Oncoimmunology"},{"key":"2619_CR22","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1038\/sj.onc.1208725","volume":"24","author":"B Zirn","year":"2005","unstructured":"Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, et al. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene. 2005;24:5246\u201351.","journal-title":"Oncogene"},{"key":"2619_CR23","first-page":"7451","volume":"63","author":"P Monti","year":"2003","unstructured":"Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, et al. The CC chemokine MCP-1\/MCP-1 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res. 2003;63:7451\u201361.","journal-title":"Cancer Res"},{"key":"2619_CR24","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/sj.bjc.6602596","volume":"92","author":"JM Arnold","year":"2005","unstructured":"Arnold JM, Huggard PR, Cummings M, Ramm GA, Chenevix-Trench G. Reduced expression of chemokine (C-C motif) ligand-2 (MCP-1) in ovarian adenocarcinoma. Br J Cancer. 2005;92:2024\u201331.","journal-title":"Br J Cancer"},{"key":"2619_CR25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1525-1438.2007.01134.x","volume":"18","author":"PM Wojnarowicz","year":"2008","unstructured":"Wojnarowicz PM, Breznan A, Arcand SL, Filali-Mouhim A, Provencher DM, et al. Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes. Int J Gynecol Cancer. 2008;18:963\u201375.","journal-title":"Int J Gynecol Cancer"},{"key":"2619_CR26","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1089\/dna.2012.1716","volume":"31","author":"C Kucukgergin","year":"2012","unstructured":"Kucukgergin C, Isman FK, Cakmakoglu B, Sanli O, Seckin S. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer. DNA Cell Biol. 2012;31:1418\u201324.","journal-title":"DNA Cell Biol"},{"key":"2619_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/dna.2013.2072","volume":"32","author":"NK Sharma","year":"2013","unstructured":"Sharma NK, Sharma SK, Gupta A, Prabhakar S, Singh R, et al. Predictive model for earlier diagnosis of suspected age-related macular degeneration patients. DNA Cell Biol. 2013;32:549\u201355.","journal-title":"DNA Cell Biol"},{"key":"2619_CR28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s10753-013-9655-6","volume":"36","author":"HF Zhang","year":"2013","unstructured":"Zhang HF, Zhao MG, Liang GB, Song ZQ, Li ZQ. Expression of pro-inflammatory cytokines and the risk of intracranial aneurysm. Inflammation. 2013;36:1195\u2013200.","journal-title":"Inflammation"},{"key":"2619_CR29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/apm.12031","volume":"121","author":"FA Araujo","year":"2013","unstructured":"Araujo FA, Rocha MA, Capettini LS, Campos PP, Ferreira MA, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice. APMIS. 2013;121:422\u201330.","journal-title":"APMIS"},{"key":"2619_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0463.2010.02705.x","volume":"119","author":"S Mera","year":"2011","unstructured":"Mera S, Tatulescu D, Cismaru C, Bondor C, Slavcovici A, et al. Multiplex cytokine profiling in patients with sepsis. APMIS. 2011;119:155\u201363.","journal-title":"APMIS"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2619-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2619-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2619-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T17:06:41Z","timestamp":1689527201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2619-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2619"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2619-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}